Wow, here in Switzerland, the word is that with the recent setbacks in clinical trials and abandoned dr-g candidates, leadership needs to save more money. Well, one site that could be jeopardized is the one in San Diego. Expect serious reductions in footprint and headcount!!
There are no replies in this thread yet. Be the first to post a reply below: